{"transactions":[{"id":1519508,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-13T20:03:08.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36810,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-24-015080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015080/form4.xml","form_type":"4"}},{"id":1519507,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:03:08.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":44906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":44906,"derivative":{"exercise_price":1.79,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":44906},"source":{"system":"sec-edgar","filing":"0001127602-24-015080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015080/form4.xml","form_type":"4"}},{"id":1534031,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-29T20:18:45.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":false,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-24-013556","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013556/form4.xml","form_type":"4"}},{"id":1534030,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-29T20:18:45.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48364,"source":{"system":"sec-edgar","filing":"0001127602-24-013556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013556/form4.xml","form_type":"4"}},{"id":1883118,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:04:39.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016433","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016433/form4.xml","form_type":"4"}},{"id":1883117,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:04:39.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40332,"source":{"system":"sec-edgar","filing":"0001127602-23-016433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016433/form4.xml","form_type":"4"}},{"id":1911577,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:23:40.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013784/form4.xml","form_type":"4"}},{"id":1911576,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:23:40.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013784/form4.xml","form_type":"4"}},{"id":2260528,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:14:45.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015370","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015370/form4.xml","form_type":"4"}},{"id":2260527,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:14:45.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015370","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015370/form4.xml","form_type":"4"}},{"id":2286818,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:15:42.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012829/form4.xml","form_type":"4"}},{"id":2286817,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:15:42.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31030,"source":{"system":"sec-edgar","filing":"0001127602-22-012829","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012829/form4.xml","form_type":"4"}},{"id":2733363,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:05:21.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014967/form4.xml","form_type":"4"}},{"id":2733362,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:05:21.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014967/form4.xml","form_type":"4"}},{"id":2738792,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:48:16.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014520/form4.xml","form_type":"4"}},{"id":2738791,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:48:16.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27006,"source":{"system":"sec-edgar","filing":"0001127602-21-014520","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014520/form4.xml","form_type":"4"}},{"id":3169354,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:46:36.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014565","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/form4.xml","form_type":"4"}},{"id":3169353,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:46:36.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014565","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/form4.xml","form_type":"4"}},{"id":3169352,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:46:36.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014565","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/form4.xml","form_type":"4"}},{"id":3169351,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:46:36.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16368,"source":{"system":"sec-edgar","filing":"0001127602-20-014565","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/form4.xml","form_type":"4"}},{"id":3546809,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-29T21:00:47.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":3466,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-19-016487","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016487/form4.xml","form_type":"4"}},{"id":3546808,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-29T21:00:47.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":6519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6519,"derivative":{"exercise_price":5.67,"expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":6519},"source":{"system":"sec-edgar","filing":"0001127602-19-016487","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016487/form4.xml","form_type":"4"}},{"id":3955201,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T21:38:10.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":7.8,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-18-015446","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015446/form4.xml","form_type":"4"}},{"id":3955200,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-27T21:38:10.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12902,"source":{"system":"sec-edgar","filing":"0001127602-18-015446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015446/form4.xml","form_type":"4"}},{"id":4340653,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-01T20:51:00.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":15.61,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-17-016063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016063/form4.xml","form_type":"4"}},{"id":4340652,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":91185,"kind":"person","name":"LEFKOWITZ ROBERT J MD","position":1,"cik":"0001226385","reported_name":"LEFKOWITZ ROBERT J MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T20:51:00.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10338,"source":{"system":"sec-edgar","filing":"0001127602-17-016063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016063/form4.xml","form_type":"4"}}]}